Fluorescein angiographic characteristic in predominantly classic and occult types of neovascular age-related macular degeneration treated with ranibizumab.
Cemal ÇavdarlıSebile ÇomçalıPınar Topcu YılmazMehmet Numan AlpPublished in: Therapeutic advances in ophthalmology (2021)
The OCC-n-AMD patients had better baseline and follow-up VA and CMT means than the PDC-n-AMD patients. However, the PDC-n-AMD patients are expected to benefit more than the OCC-n-AMD patients in terms of VA gains.